Attention:
Card image cap

Fundamentals of Value-Based Care: Risk Capability and the Ability to Optimize Value For CINs/ACOs


Level: Advanced
Runtime: 92 minutes
Recorded Date: October 25, 2018
Click here to share this program
Printer-Friendly Version
Closed Caption

Agenda


  • Defined strategies focused at optimizing the value of ACOs/CINs
  • Developed funds flow methodologies used to distribute value-based rewards across eligible providers
  • Optimal legal structures and key considerations to achieve enterprise sustainability across your CIN/ACO
Runtime: 1 hour and 30 minutes
Recorded: October 25, 2018
For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

Accountable Care Organizations (ACOs) and Clinically Integrated Networks (CINs) are highly structured collaborations between health systems and clinical providers designed to coordinate the resources needed to achieve Triple Aim goals and create a legal “safe harbor” for groups to affiliate in innovative ways for greater efficiency and community benefit. By thoughtfully designing processes that manage medical care throughout the spectrum of services and utilizing the most efficient, evidenced-based practices, these clinical networks are intended to achieve the best quality of care at the lowest cost value. These legal entities are also utilize to joint contract across payers/employers for rewards attributed to demonstrated improvement.

This program was recorded on October 25th, 2018.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Matthew Fadel

Senior Manager
Sg2

As a member of Sg2’s Consulting team, Matt focuses on physician-hospital alignment models (eg, accountable care organizations [ACOs], clinically integrated networks [CINs], co-management) and enterprise strategic planning, both service line–wide and enterprise-wide.

Card image cap

John Kirsner

Partner
Jones Day

With 25 years experience, John Kirsner has a national practice representing health systems and large provider organizations on cutting-edge reform-driven transactions. John has assisted in the formation and operation of more than 20 clinically integrated networks. He has assisted clients in more than a dozen MSSP ACOs. He advises ACOs on creative uses of the ACO waivers. He assists in the negotiation of shared savings arrangements with payers as well as hospital quality and efficiency programs and related co-management ventures. John is extremely conversant on the operation and regulatory implications of health care network messenger models. He has exceptional experience in the area of payer/provider contracting, including payer financial distress and preference matters.

John has led multiple engagements creating innovative affiliations between large multispecialty physician group practices and hospital systems. He has created working foundation models, models similar to the Kaiser model, as well as looser affiliation structures. He has considered the impact of equity and debt financing in the context of these transactions (including situations where a provider is in financial distress) and has worked through the medical staff implications on such affiliation structures. He also has extensive experience in joint venture, joint operating agreement, and entity formation. He represents hospitals and other providers in transactional work, including M&A.

John serves as board advisor to several health care clients. He is past chair of the Ohio State Bar Association Health Care Committee and also served as the business development partner for the Columbus Office of Jones Day from 2015 to 2018.


Card image cap

Similar Courses

Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
76 minutes
But I’m Afraid of Needles: The Sale of Health Care Assets
This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
53 minutes
Conservatorship Criteria in Context: The Britney Spears Case
The Britney Spears conservatorship case has brought a lot of attention to the Conservatorships and Guardianship laws throughout the country. In this program, Dr. Brian Russell uses his expertise to provde some useful legal context to the case, provide lawyers with a better understanding of where the pitfalls are and how they can do right by their clients.

Dr. Brian Russell

$75

Add to Cart
Card image cap
86 minutes
COVID-19 Relief Funding & Reopening America: What's Really Happening in Congress
Please join a distinguished panel who will share their thoughts on how best to safely and gradually re-open business across America.

American Bankruptcy Institute

$115

Add to Cart
Previous Next